FlashFeed

FDA Advisory Panel Weighs Easing Access Restrictions on Seven Peptides

An FDA advisory panel is reviewing scientific evidence on seven different peptides, weighing whether current access restrictions should be eased. Favourable votes from the panel would pave the way for broader availability of these compounds for patients and physicians. The outcome could significantly affect the US market for peptide-based treatments and supplements.